Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HEALinc (Health, Self-Efficacy, Analytics, and Life-Design Incubator) is a Bahamas-based R&D organization and global platform founded in 2018 by Dr. Desirée Cox. The company focuses on advancing longevity, regenerative medicine, and whole-person health through its annual Future Health Summits and the development of regulatory frameworks like the 2024 Longevity and Regenerative Therapies Act (LARTA). HEALinc serves as an incubator and 'catalytic engine' for translational science, connecting scientists, investors, and policymakers to accelerate the deployment of safe and ethical cellular and gene therapies. It operates as a 'fast track' test bed for cutting-edge health solutions in a sovereign, data-driven environment, leveraging the unique regulatory landscape of The Bahamas to facilitate clinical research and medical tourism.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HEALinc.